Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Support Care Cancer. 2020 Sep 8;29(4):2231–2238. doi: 10.1007/s00520-020-05733-1

Table 2:

Patient characteristics

Total number of patients who completed HSCT 350
Age (median) 54 (range 8-75)
Sex (male/female) 207 (59.1%) / 143 (40.9%)
Primary disease
 - Multiple Myeloma
 - Non-Hodgkin’s Lymphoma
 - Hodgkin’s Lymphoma
 - Leukemia
 - Other

104 (29.7%)
99 (28.3%)
28 (8.0%)
95 (27.1%)
24 (6.9%)
Transplant type
 - Allogeneic
 - Autoloaous

143 (40.9%)
207 (59.1%)

(HSCT: Hematopoietic stem cell transplant)